comparison with total operating revenue, SG&A per revenue decreased from 7.2% in 2018 to 6.7% in 2019 due to budgeting control policy. Cost and expense from delayed project In the third quarter of 2018, the

2Q 2020 P&L SNAPSHOT AND ANALYSIS (THB mn) 2Q 2020 2Q 2019 % YoY 1Q 2020 % QoQ Operating revenues 365.4 2,026.0 (82.0%) 1,486.6 (75.4%) Other revenues 160.1 255.9 (37.4%) 505.8 (68.3%) Total Revenue

-Up 11 14 27% Revenue from Franchising 5 5 0% Total Operating Revenue 264 340 29% Other Income 4 3 (25%) Total Revenue 268 343 28% Key Drivers Q4/22 Q4/23 Change+/(-) Number of branches at 31 Mar 53 61

(Unreviewed) as follows: Performance Overview For the first quarter of 2019, the net profit of the Company and its subsidiary was 496.30 million baht. The total income was 1,029.51 million baht, financial cost

) as follows: Performance Overview For the first quarter of 2019, the net profit of the Company and its subsidiary was 496.30 million baht. The total income was 1,029.51 million baht, financial cost was

of the Company and its subsidiary was 464.66 million baht. The total income was 1,109.77 million baht, financial cost was 249.84 million baht, the selling and administrative expense was 136.79 million

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

RP-AC 001/2019 February 26, 2019 Subject Clarification of 2018 Operating Results To Directors and Managers of the Stock Exchange of Thailand Richy Place 2002 Public Company Limited (RICHY) would like

the quarter 3/2017 (April 1 – June 30, 2017), the Company’s total revenues amounted to 1,309.61 million baht, increased by 78.61 million baht or 6.39% comparing to the same period last year due to the

Company and its subsidiaries for the three-month and six-month period ended June 30, 2018. The Company would like to clarify on the operating results as follows: Revenues - Total 3-month and 6-month